1 not yet recruiting, 1 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Gastric Bypass Surgery: new trials by email Literature Review of Gastric Bypass Surgery trials Research Report on Gastric Bypass Surgery
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anakinra for the Treatment of Postprandial Hypoglycemia in a Patient With Total Gastrectomy and End-Stage Renal Disease Anakinra (interleukin-1 receptor antagonist), Placebo Comparator (0.9% NaCl) - Postprandial Hypoglycemia, End-stage Renal Disease (ESRD) | Phase 2 | Not yet recruiting | Marc Donath | 1 | 2026-07-01 | 2026-05-12 |
| The Effects of Probiotic Supplementation on the Results of Gastric Bypass Surgery probiotic, Placebo - Gastric Bypass Surgery | Phase 2 / Phase 3 | Unknown | National Nutrition and Food Technology Institute | 50 | 2015-09-01 | 2016-03-15 |
Glucose Metabolism Disorders (1) · Hypoglycemia (1) · Inflammation (1) · Kidney Failure, Chronic (1)
Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Interleukin 1 Receptor Antagonist Protein (1) · Probiotics (1) · Receptors, Interleukin-6 (1)
Marc Donath (1) · National Nutrition and Food Technology Institute (1)
Iran (1) · Switzerland (1)
Matthias Hepprich, PD Dr. med. (1)
2025 (1)